Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older
Clinical trial NCT04974216 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04974216
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2024-07-15
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.